CANNABIS STARTUP & EARLY-STAGE FINANCING
Early-stage cannabis businesses in California face a financing environment unlike any other industry. Access to conventional bank financing remains largely unavailable due to federal Schedule I classification, which means cannabis startups rely disproportionately on private capital — angel investors, family offices, strategic investors, and VC funds — structured through instruments that require careful customization for the California cannabis regulatory environment. The Law Office of Shay Aaron Gilmore provides early-stage financing counsel for California cannabis startups and their investors, covering instrument selection, DCC disclosure compliance, and Regulation D private placement structuring.
The most widely-used industry-standard financing documents — the NVCA Model Legal Documents — provide a tested baseline for cannabis seed and Series A rounds, but they require significant modification to account for California’s investor disclosure requirements, the absence of federal bankruptcy protection, and the risk that standard management rights and board composition provisions may inadvertently trigger DCC owner-level regulatory obligations for investors. This firm has the cannabis regulatory expertise to make those modifications correctly.
Recognized By
Super Lawyers® Magazine
Top 20 California Cannabis Lawyers
The Daily Journal
California NORML
Global Top 200 Cannabis Lawyer
Cannabis Law Journal
Instrument Selection for Cannabis Startups
The choice of financing instrument for an early-stage cannabis round depends on the stage of the company, the regulatory posture of incoming investors, and the company’s formation jurisdiction.
SAFE Notes (Simple Agreement for Future Equity): The Y Combinator SAFE is widely used for early-stage cannabis fundraising. A cannabis-specific SAFE — developed in collaboration with Y Combinator — incorporates a mechanism requiring investors and the company to comply with state and local cannabis regulations when needed. The cannabis SAFE is designed for use with corporations (not LLCs) and does not accrue interest or carry a maturity date, making it simpler than convertible notes for seed-stage rounds. Key terms include: valuation cap, discount rate, and pro-rata rights. For investors who will receive equity upon conversion, DCC financial interest holder or owner disclosure obligations apply from the point of conversion.
Convertible Notes: Convertible notes are debt instruments that convert into equity upon a triggering event (typically a priced round). Unlike SAFEs, convertible notes carry an interest rate and a maturity date. Interest rates in cannabis convertible note deals typically range from 6–10% per annum. For California cannabis companies, convertible note agreements must be reviewed to ensure that lender rights — including acceleration rights and any profit-sharing provisions — do not trigger DCC financial interest holder disclosure obligations under 4 CCR §15004 prior to conversion.
Preferred Stock (Series Seed / Series A): For companies ready for a priced round, the NVCA Certificate of Incorporation (updated October 2025) and the full suite of NVCA financing documents — Stock Purchase Agreement, Investors’ Rights Agreement, Voting Agreement, and Right of First Refusal and Co-Sale Agreement (updated April 2026) — provide the industry standard framework. For cannabis companies, each of these documents requires review and modification to address: (a) DCC investor disclosure obligations, (b) management rights provisions that could trigger DCC owner-level classification, (c) the absence of federal bankruptcy protection, and (d) federal court venue complications.
Regulation D and Accredited Investor Requirements
Most early-stage cannabis financings are structured as private placements exempt from SEC registration under Regulation D, Rule 506. Under Rule 506(b), a cannabis company may raise capital from up to 35 non-accredited investors and an unlimited number of accredited investors, so long as no general solicitation occurs. Under Rule 506(c), a company may broadly advertise the offering but must restrict sales exclusively to accredited investors and take reasonable steps to verify accredited investor status.
The SEC’s guidance on accredited investor verification under Rule 506(c) provides that an investor who invests at least $200,000 (individual) or $1,000,000 (entity) may be presumed accredited without requiring the investor to produce tax returns, bank statements, or professional verification letters — a simplification that reduces friction in cannabis fundraising.
An individual qualifies as an accredited investor under 17 CFR §230.501 by meeting one of the following: (1) net worth exceeding $1,000,000 excluding primary residence, (2) individual income exceeding $200,000 (or $300,000 joint) in each of the prior two years with reasonable expectation of the same in the current year, or (3) holding a Series 7, Series 65, or Series 82 license in good standing.
FinCEN, Banking, and the Cannabis Financing Environment
California cannabis companies face persistent banking access challenges that directly affect early-stage financing. FinCEN’s 2014 cannabis banking guidance requires financial institutions serving cannabis businesses to file Suspicious Activity Reports (SARs) for virtually every transaction, creating compliance burdens that have kept major banks out of cannabis banking. While cannabis-friendly state-chartered banks and credit unions provide deposit and basic banking services, access to conventional business lines of credit, SBA loans, and institutional lending remains unavailable to most licensed cannabis operators.
For investors and startups, this means:
Capital contributions and investment proceeds must flow through cannabis-compliant banking relationships
Wire transfers for investment closings require coordination with the company’s cannabis-banking institution
Escrow services for investment transactions must be provided by counsel or a cannabis-compliant escrow provider
The SAFER Banking Act, which would create an explicit federal safe harbor for financial institutions serving cannabis businesses, remains pending in Congress as of May 2026
Cannabis vs. Hemp Early-Stage Financing Comparison
| Issue | Cannabis Startup Financing | Hemp Startup Financing |
|---|---|---|
| Banking access | Limited — FinCEN SAR requirements; cannabis-friendly institutions only | Conventional banking available (Farm Bill compliant since 2018) |
| SAFE note suitability | Cannabis SAFE required (Y Combinator modification) | Standard Y Combinator SAFE broadly suitable |
| NVCA document use | Required with cannabis-specific modifications | Usable as-is for standard preferred stock rounds |
| Reg D compliance | Required — standard Regulation D Rule 506 analysis applies | Required — same standard Regulation D analysis applies |
| DCC investor disclosure | FIH disclosure required for all financial interest holders | No state investor disclosure obligation |
| Federal court venue | Problematic — cannabis remains Schedule I; arbitration preferred | Federal court available |
Representative Matters
Secured Investment by an Out-of-State Investor (Cannabis Retail Development): Represented an investor from outside California making an early-stage secured investment in a cannabis retail development company operating multiple California locations. The engagement required structuring the investment agreements to comply with DCC financial interest holder disclosure requirements under 4 CCR §15004, coordinating the disclosure process with the DCC, and safeguarding the investor’s security position while working collaboratively with the company’s counsel to meet the company’s capital needs.